Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance
- PMID: 21637903
Topical rosacea therapy: the importance of vehicles for efficacy, tolerability and compliance
Abstract
Many topical medications are available for the treatment of papulopustular rosacea. While treatments contain metronidazole, azelaic acid, or sodium sulfacetamide-sulfur as the active ingredient, the composition of the vehicle formulations varies widely. These vehicles come in gels, creams, lotions and foams; some ingredients are common to many vehicles, while some vehicles contain unique ingredients designed to optimize skin penetration and delivery of the active drug to its target. Vehicles can also influence tolerability, which is always a concern in patients with heightened skin sensitivity, and compliance, which is typically lower for topical treatments than oral treatments. Ideally, the vehicle of any rosacea treatment should enhance drug delivery, be nonirritating and be easy to use. Ingredients that help repair barrier function are also desirable. This review will focus on the key components of the vehicles from the most commonly used topical therapies for papulopustular rosacea and how vehicle formulations influence the delivery of active ingredient, skin barrier repair, tolerability and compliance.
Similar articles
-
Importance of vehicles in acne therapy.J Drugs Dermatol. 2011 Jun;10(6):s17-23. J Drugs Dermatol. 2011. PMID: 21780342
-
Treatment of papulopustular rosacea with sodium sulfacetamide 10%/sulfur 5% emollient foam.J Drugs Dermatol. 2009 Mar;8(3):299-304. J Drugs Dermatol. 2009. PMID: 19271381
-
Rosacea and its topical management.Skin Therapy Lett. 2009 Feb;14(2):1-3. Skin Therapy Lett. 2009. PMID: 19330270
-
A clinical overview of azelaic acid.Cutis. 2006 Feb;77(2 Suppl):12-6. Cutis. 2006. PMID: 16566283 Review.
-
Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials.Arch Dermatol. 2006 Aug;142(8):1047-52. doi: 10.1001/archderm.142.8.1047. Arch Dermatol. 2006. PMID: 16924055 Review.
Cited by
-
Impact of Topical Vehicles and Cutaneous Delivery Technologies on Patient Adherence and Treatment Outcomes in Acne and Rosacea.J Clin Aesthet Dermatol. 2023 May;16(5):26-34. J Clin Aesthet Dermatol. 2023. PMID: 37288283 Free PMC article. Review.
-
Enhancing Topical Pharmacotherapy for Acne and Rosacea: Vehicle Choices and Outcomes.J Clin Aesthet Dermatol. 2022 May;15(5):36-40. J Clin Aesthet Dermatol. 2022. PMID: 35642224 Free PMC article. Review.
-
[Topical therapy of rosacea].Hautarzt. 2013 Jul;64(7):494-9. doi: 10.1007/s00105-012-2518-5. Hautarzt. 2013. PMID: 23780475 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical